Human Holdings Co., Ltd. (TYO:2415)
Japan · Delayed Price · Currency is JPY 1,518.00
-3.00 (-0.20%)
Jun 4, 2026, 3:30 PM JST
Human Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 102,539 | 100,328 | 95,895 | 91,574 | 86,292 | |
Revenue Growth (YoY) | 2.20% | 4.62% | 4.72% | 6.12% | 0.56% |
Cost of Revenue | 76,189 | 74,546 | 71,313 | 68,797 | 64,491 |
Gross Profit | 26,350 | 25,782 | 24,582 | 22,777 | 21,801 |
Selling, General & Admin | 22,736 | 21,949 | 20,952 | 20,055 | 18,856 |
Amortization of Goodwill & Intangibles | - | 23 | 22 | 22 | 18 |
Operating Expenses | 22,782 | 22,385 | 21,437 | 20,675 | 19,346 |
Operating Income | 3,568 | 3,397 | 3,145 | 2,102 | 2,455 |
Interest Expense | -69 | -49 | -36 | -29 | -20 |
Interest & Investment Income | 58 | 15 | 10 | 11 | 9 |
Currency Exchange Gain (Loss) | - | 2 | 32 | 49 | 48 |
Other Non Operating Income (Expenses) | 329 | 210 | 142 | 383 | 217 |
EBT Excluding Unusual Items | 3,886 | 3,575 | 3,293 | 2,516 | 2,709 |
Gain (Loss) on Sale of Investments | -80 | -70 | -45 | -73 | -2 |
Gain (Loss) on Sale of Assets | - | - | - | 7 | 3 |
Asset Writedown | -237 | -11 | -100 | -71 | -48 |
Other Unusual Items | -73 | 139 | 26 | - | -1 |
Pretax Income | 3,496 | 3,633 | 3,174 | 2,379 | 2,661 |
Income Tax Expense | 1,280 | 1,026 | 1,017 | 927 | 1,015 |
Net Income | 2,216 | 2,607 | 2,157 | 1,452 | 1,646 |
Net Income to Common | 2,216 | 2,607 | 2,157 | 1,452 | 1,646 |
Net Income Growth | -15.00% | 20.86% | 48.55% | -11.79% | 14.38% |
Shares Outstanding (Basic) | 10 | 10 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 10 | 10 | 11 | 11 | 11 |
Shares Change (YoY) | - | -2.74% | -1.91% | - | - |
EPS (Basic) | 213.53 | 251.21 | 202.15 | 133.48 | 151.31 |
EPS (Diluted) | 213.53 | 251.21 | 202.15 | 133.48 | 151.31 |
EPS Growth | -15.00% | 24.27% | 51.44% | -11.79% | 14.38% |
Free Cash Flow | 2,541 | 559 | 3,892 | 1,830 | 1,107 |
Free Cash Flow Per Share | 244.85 | 53.86 | 364.75 | 168.23 | 101.77 |
Dividend Per Share | - | 75.500 | 62.500 | 27.000 | 30.500 |
Dividend Growth | - | 20.80% | 131.48% | -11.47% | 15.09% |
Gross Margin | 25.70% | 25.70% | 25.63% | 24.87% | 25.26% |
Operating Margin | 3.48% | 3.39% | 3.28% | 2.30% | 2.84% |
Profit Margin | 2.16% | 2.60% | 2.25% | 1.59% | 1.91% |
Free Cash Flow Margin | 2.48% | 0.56% | 4.06% | 2.00% | 1.28% |
EBITDA | 4,562 | 4,313 | 4,055 | 3,008 | 3,411 |
EBITDA Margin | 4.45% | 4.30% | 4.23% | 3.28% | 3.95% |
D&A For EBITDA | 994 | 916 | 910 | 906 | 956 |
EBIT | 3,568 | 3,397 | 3,145 | 2,102 | 2,455 |
EBIT Margin | 3.48% | 3.39% | 3.28% | 2.30% | 2.84% |
Effective Tax Rate | 36.61% | 28.24% | 32.04% | 38.97% | 38.14% |
Advertising Expenses | - | 2,204 | 2,145 | 2,551 | 2,436 |